A quiet revolution in tuberculosis diagnostics is here. 🧪🌍

This NEJM study shows that MiniDock MTB, a rapid swab-based molecular test, delivers Xpert-level accuracy with minimal training and no adverse events—all in a near–point-of-care format. ⏱️🧠

Key insights: 🔹 Sensitivity: 85.7% (sputum), 79.6% (tongue) 🔹 Specificity: >97–99% 🔹 Strong performance vs smear microscopy (+24% sensitivity) 🔹 Usability score: 75—ready for real-world deployment

The implications are profound: 👉 Noninvasive testing for patients unable to produce sputum 👉 Decentralized diagnostics in resource-limited settings 👉 A realistic path to closing the global TB detection gap

From central labs to community clinics—this is how access scales. 🚀

📖 Yerlikaya et al., NEJM 2026

#Tuberculosis #GlobalHealth #Diagnostics #PointOfCare #PublicHealth #InfectiousDiseases #PrecisionMedicine #MedicalInnovation #HealthEquity #TBElimination